key: cord-0978407-peks0sxq
authors: Zandi, Milad; Soltani, Saber
title: Severe acute respiratory syndrome coronavirus‐2 and its structural proteins
date: 2021-08-05
journal: J Cell Physiol
DOI: 10.1002/jcp.30546
sha: ac0a6e3911d60c9fd25e44d8f358ed6de09ee97f
doc_id: 978407
cord_uid: peks0sxq

nan

Severe acute respiratory syndrome coronavirus-2 and its structural proteins To The Editor, We read with great interest a review that provides a systematic evaluation of the most recent in vitro and in vivo investigations targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry, although authors showed that SARS-CoV-2 has five structural proteins including the S (spike), M (membrane), N (nucleocapsid), and E (envelope) proteins, and the HE (hemagglutinin esterase) in fig. 2 (Seyedpour et al., 2021) . However, based on the scientific evidence which is described in this letter, SARS-CoV-2 lacks HE so it cannot be considered as a structural protein in SARS-CoV-2 (Chan et al., 2020; Mittal et al., 2020; Zandi et al., 2021) . ORF3a, 3b, 6, 7a, 7b, 8, 9b, 9c, and 10 . SARS-CoV-2 does not contain HE gene (Chan et al., 2020; Zhang et al., 2021) . However, other beta-coronaviruses such as HKU1-CoV and OC43-CoV of Embecovirus subgenera bear HE gene and can encode HE (Hulswit et al., 2019) .

In conclusion, SARS-CoV-2 as a beta-coronavirus of Sarbecovirus lacks HE and encodes four structural proteins thus HE cannot be used as a drug target against COVID-19.

Saber Soltani 1,2 1

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

The new scope of virus taxonomy: Partitioning the virosphere into 15 hierarchical ranks

Emergence of bat-related betacoronaviruses: Hazard and risks

Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A

COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2

Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)

Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies

Role of glycoprotein hemagglutinin-esterase in COVID-19 pathophysiology?

An overview of current knowledge of deadly CoVs and their interface with innate immunity